Loading...
Treatment of esophagogastric junction carcinoma: An unsolved debate
The incidence of esophagogastric junction adenocarcinoma (AEG) is increasing worldwide. Barrett’s esophagus (BE) associated with dysplasia is the main risk factor for the development of cancer. Currently, screening programs to individuate and eradicate BE represent the best way to reduce AEG cancer....
Saved in:
Published in: | World J Gastroenterol |
---|---|
Main Authors: | , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Baishideng Publishing Group Inc
2015
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4402289/ https://ncbi.nlm.nih.gov/pubmed/25914451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i15.4427 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|